NYSE:BLCOMedical Equipment
Bausch + Lomb (NYSE:BLCO): Assessing Valuation After ASANA Lens Launch and Strong Clinical Updates
If you have been following Bausch + Lomb (NYSE:BLCO), the latest surge in its stock price may have grabbed your attention. After unveiling its new ASANA gas permeable lenses in the U.S., a portfolio geared toward patients with challenging vision needs, the company saw shares jump nearly 3%. This launch, backed by positive feedback on the product’s durability and versatility, seems to have landed well with investors who are watching for signs that Bausch + Lomb's innovation engine is gaining...